ERBB2 and osteosarcoma: Among the osteosarcomas, mutations to HER2 have been detected at a relatively high rate, but the reported frequency of HER2 amplification or overexpression in osteosarcoma varies (although most reports are in the 30–60% range, there have been reports of 0–100%).